
Tech meets healthcare: nuvoteQ's AWS success
In response to the COVID-19 pandemic, nuvoteQ, a South African medtech company, partnered with iOCO to leverage AWS technology, enhancing their capability to manage vast clinical trial data. This case study highlights how the strategic AWS implementation facilitated nuvoteQ’s critical role in the global vaccine rollout, emphasising scalability, security, and operational efficiency.
"The robustness of AWS infrastructure has expanded our reach to over 20 countries, marking a significant milestone in global healthcare technology"
Adriaan Kruger
Co-founder and CEO of nuvoteQ
Global health crisis and technological response:
Amidst the urgent global health challenges posed by COVID-19, nuvoteQ emerged as a key player in accelerating the vaccine rollout. Their innovative electronic direct capturing (EDC) platform, Nukleus, hosted on AWS and developed in collaboration with iOCO, streamlined data collection for clinical trials, particularly in India, where they assisted a major pharmaceutical company in navigating the pandemic's complexities.
Challenges faced:
The task at hand was the rapid deployment of a reliable, scalable platform capable of handling extensive clinical trial data, crucial for the timely distribution of vaccines in one of the world’s most populous countries.
iOCO’s AWS solution:
Partnering with iOCO, nuvoteQ leveraged AWS's cloud platform for its unparalleled advantages in cost reduction, operational efficiency, and enhanced patient care. Key benefits included:
- Quick deployment: Reducing a typical 8-12 week implementation process to just two weeks.
- Scalability: Effectively handling increased data volume and usage across multiple countries.
- Security and compliance: Ensuring data integrity and regulatory adherence in diverse global environments.
Super-tuning the AWS environment:
As an AWS Well Architected Partner, iOCO conducted a comprehensive review to identify areas for efficiency gains. This led to:
- Improved resource utilisation: Enhanced performance monitoring and cost management.
- Strengthened security: Ensuring data encryption and unauthorised access prevention.
- Regulatory compliance: Maintaining adherence to global data management standards.
Outcomes and benefits:
The AWS solution provided by iOCO was key to nuvoteQ’s successful contribution to the COVID-19 vaccine rollout, particularly in India. Key benefits included:
- Stable and reliable infrastructure capable of supporting large-scale global operations.
- Cost-effective solutions enhancing the financial viability of the project.
- Secure data handling, instilling confidence in international clients.
Conclusion:
The partnership between iOCO and nuvoteQ, underpinned by AWS technology, not only facilitated an expedited vaccine rollout in response to a global crisis but also set new standards in medtech data management and scalability.
About nuvoteQ
Nuvoteq is a provider of digital technology solutions for clinical and pharmaceutical research. Their offerings include powerful software products that adhere to strict industry standards for secure applications. Their solutions are designed for flexibility, adaptability, and cost-effectiveness, catering to the specific needs of clinical research organisations. Nuvoteq's products are developed in Africa and have a global reach, trusted by leading research organizations.
For more information, visit their website at Nuvoteq.
Key Technologies
- AWS